PROCTER & GAMBLE HEALTH | PLETHICO PHARMA | PROCTER & GAMBLE HEALTH/ PLETHICO PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.5 | -0.1 | - | View Chart |
P/BV | x | 10.5 | 0.0 | 62,731.2% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH PLETHICO PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
PLETHICO PHARMA Mar-14 |
PROCTER & GAMBLE HEALTH/ PLETHICO PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 254 | 2,112.4% | |
Low | Rs | 3,883 | 31 | 12,425.6% | |
Sales per share (Unadj.) | Rs | 740.7 | 604.6 | 122.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | 32.5 | 425.5% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 51.3 | 302.2% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 473.7 | 94.5% | |
Shares outstanding (eoy) | m | 16.60 | 34.07 | 48.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.2 | 2,646.5% | |
Avg P/E ratio | x | 33.5 | 4.4 | 762.0% | |
P/CF ratio (eoy) | x | 29.8 | 2.8 | 1,072.9% | |
Price / Book Value ratio | x | 10.3 | 0.3 | 3,431.3% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 4,859 | 1,579.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 1,547 | 133.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 20,598 | 59.7% | |
Other income | Rs m | 184 | 419 | 43.8% | |
Total revenues | Rs m | 12,480 | 21,017 | 59.4% | |
Gross profit | Rs m | 3,247 | 2,938 | 110.5% | |
Depreciation | Rs m | 281 | 642 | 43.8% | |
Interest | Rs m | 8 | 1,747 | 0.4% | |
Profit before tax | Rs m | 3,142 | 968 | 324.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | -138 | -612.3% | |
Profit after tax | Rs m | 2,295 | 1,107 | 207.3% | |
Gross profit margin | % | 26.4 | 14.3 | 185.1% | |
Effective tax rate | % | 27.0 | -14.3 | -188.7% | |
Net profit margin | % | 18.7 | 5.4 | 347.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 18,877 | 62.0% | |
Current liabilities | Rs m | 6,791 | 11,896 | 57.1% | |
Net working cap to sales | % | 40.0 | 33.9 | 118.1% | |
Current ratio | x | 1.7 | 1.6 | 108.7% | |
Inventory Days | Days | 263 | 78 | 336.4% | |
Debtors Days | Days | 343 | 198 | 173.6% | |
Net fixed assets | Rs m | 10,617 | 14,269 | 74.4% | |
Share capital | Rs m | 166 | 341 | 48.7% | |
"Free" reserves | Rs m | 7,265 | 15,798 | 46.0% | |
Net worth | Rs m | 7,431 | 16,139 | 46.0% | |
Long term debt | Rs m | 0 | 4,706 | 0.0% | |
Total assets | Rs m | 22,330 | 33,146 | 67.4% | |
Interest coverage | x | 409.1 | 1.6 | 26,314.3% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.6 | 88.6% | |
Return on assets | % | 10.3 | 8.6 | 119.8% | |
Return on equity | % | 30.9 | 6.9 | 450.3% | |
Return on capital | % | 42.4 | 13.0 | 325.4% | |
Exports to sales | % | 0 | 21.4 | 0.0% | |
Imports to sales | % | 13.1 | 15.2 | 85.8% | |
Exports (fob) | Rs m | NA | 4,402 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 3,136 | 51.2% | |
Fx inflow | Rs m | 1,465 | 4,402 | 33.3% | |
Fx outflow | Rs m | 1,605 | 3,184 | 50.4% | |
Net fx | Rs m | -140 | 1,219 | -11.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 2,437 | 96.8% | |
From Investments | Rs m | -215 | -6,265 | 3.4% | |
From Financial Activity | Rs m | -985 | 2,490 | -39.5% | |
Net Cashflow | Rs m | 1,160 | 24 | 4,739.8% |
Indian Promoters | % | 0.0 | 57.8 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.3 | 19.4 | 104.4% | |
FIIs | % | 7.6 | 2.7 | 281.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 42.3 | 114.0% | |
Shareholders | 56,730 | 16,430 | 345.3% | ||
Pledged promoter(s) holding | % | 0.0 | 85.7 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | PLETHICO PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.55% | -4.91% | 1.18% |
1-Month | -7.47% | -1.24% | -0.75% |
1-Year | -3.02% | -70.21% | 61.82% |
3-Year CAGR | -9.12% | -66.86% | 18.16% |
5-Year CAGR | 5.75% | -51.20% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the PLETHICO PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of PLETHICO PHARMA the stake stands at 57.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of PLETHICO PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
PLETHICO PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of PLETHICO PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.